Site internet: http://www-igbmc.u-strasbg.fr/events/congress/89
Lipid metabolites are ranking in unique position in mediating specific cell responses. Indeed, some of them act as signaling molecules to target Ras pathway or protein kinases C and ultimately regulate gene expression.
Lipidomics aims at characterizing and measuring lipid molecular species as well as their interactions with partners such as lipids, proteins or other metabolites. It is a branch of the metabolomics fields, but represents a discipline per se through the structural and functional diversity of lipids compared with other metabolites or second messengers such as calcium or cGMP or cAMP.
Numerous pathological conditions are linked to impaired lipid metabolism, and lipidomics is instrumental in better understanding the molecular mechanisms, which underlie disease, and in identifying biomarkers.
Lipidomics is addressed in numerous teams at Strasbourg University. The goal of this symposium is to share major advances in lipid research and lipidomics in health and disease.
1er plan de gauche à droite : Pr Lina OBEID, Dr Pierre ANTONY, Dr Catherine TOMASETTO
2ème plan de gauche à droite : Pr Yusuf HANNUN, Dr Nicolas VITALE, Pr Sylviane MULLER
3ème plan de gauche à droite : Dr Dino MORAS, Dr Daniel METZGER, Pr Michel LAGARDE, Dr Florence SCHAFFNER
4ème plan de gauche à droite : Dr Roméo RICCI, Dr Irwin DAVIDSON, Jean-Luc TOUSSAINT
5ème plan de gauche à droite : Pierre-Alain MENDLER, Dr Christophe ROMIER, Alain LITT
Yusuf HANNUN (Keynote) – Stony Brook University, NY; USA